Quality control of multidrug resistance assays in adult acute leukemia: Correlation between assays for P-glycoprotein expression and activity

H. J. Broxterman, P. Sonneveld, N. Feller, G. J. Ossenkoppele, D. C R Währer, C. A. Eekman, M. Schoester, J. Lankelma, H. M. Pinedo, B. Löwenberg, G. J. Schuurhuis

Research output: Contribution to journalArticle

Abstract

We have compared multiple assays for the P-glycoprotein (Pgp/MDR1) phenotype in fresh and thawed adult acute leukemia to validate and quantitate measures for the expression and function of Pgp. The results are related to the Pgp-expressing KB8 and KB8-5 cell lines. The most sensitive assay was the measurement of modulation of the rhodamine 123 (R123) fluorescence by 2 μmol/L PSC833, followed by the modulation of the probe calcein-AM. We also found a good intralaboratory and interlaboratory correlation between the values of the R123/PSC833 assay for fresh as well as thawed samples. In addition, the effects of PSC833 on 3H-daunorubicin (DNR) accumulation, DNR fluorescence, and 3H-vincristine accumulation were very similar. The correlation between the DNR/PSC833 and R123/PSC833 test was r = .86 (N = 51). The modulation of drug accumulation by 8 μmol/L verapamil was the same as the PSC833 effect for DNR (117%, N = 21), but was higher for vincristine in every single case (161% v 121%, N = 22; P <.001), indicating additional verapamil effects, not related to Pgp. The correlation of the staining of viable cells for Pgp with the monoclonal antibody MRK16 was r = .77 (N = 52) for the R123/PSC833 functional test and r = .84 (N = 50) for the DNR/PSC833 test. From these results it could be calculated that a maximal increase of the mean DNR accumulation of about 50% can be achieved by blocking Pgp pump activity with PSC833 in leukemic blast samples with the highest mean Pgp expression. Subpopulations of blast cells with higher Pgp activity are likely to be present. Their relevance has to be studied further. The methods outlined here allow the reliable, quantitative monitoring of the Pgp/MDR1 phenotype in leukemias in multicentered, clinical Pgp modulation studies.

Original languageEnglish (US)
Pages (from-to)4809-4816
Number of pages8
JournalBlood
Volume87
Issue number11
StatePublished - Jun 1 1996
Externally publishedYes

Fingerprint

Multiple Drug Resistance
P-Glycoprotein
Quality Control
Quality control
Assays
Leukemia
Daunorubicin
Rhodamine 123
Modulation
Vincristine
Verapamil
Fluorescence
Phenotype
valspodar
Monoclonal Antibodies
Cells
Pumps
Staining and Labeling
Cell Line
Monitoring

ASJC Scopus subject areas

  • Hematology

Cite this

Broxterman, H. J., Sonneveld, P., Feller, N., Ossenkoppele, G. J., Währer, D. C. R., Eekman, C. A., ... Schuurhuis, G. J. (1996). Quality control of multidrug resistance assays in adult acute leukemia: Correlation between assays for P-glycoprotein expression and activity. Blood, 87(11), 4809-4816.

Quality control of multidrug resistance assays in adult acute leukemia : Correlation between assays for P-glycoprotein expression and activity. / Broxterman, H. J.; Sonneveld, P.; Feller, N.; Ossenkoppele, G. J.; Währer, D. C R; Eekman, C. A.; Schoester, M.; Lankelma, J.; Pinedo, H. M.; Löwenberg, B.; Schuurhuis, G. J.

In: Blood, Vol. 87, No. 11, 01.06.1996, p. 4809-4816.

Research output: Contribution to journalArticle

Broxterman, HJ, Sonneveld, P, Feller, N, Ossenkoppele, GJ, Währer, DCR, Eekman, CA, Schoester, M, Lankelma, J, Pinedo, HM, Löwenberg, B & Schuurhuis, GJ 1996, 'Quality control of multidrug resistance assays in adult acute leukemia: Correlation between assays for P-glycoprotein expression and activity', Blood, vol. 87, no. 11, pp. 4809-4816.
Broxterman HJ, Sonneveld P, Feller N, Ossenkoppele GJ, Währer DCR, Eekman CA et al. Quality control of multidrug resistance assays in adult acute leukemia: Correlation between assays for P-glycoprotein expression and activity. Blood. 1996 Jun 1;87(11):4809-4816.
Broxterman, H. J. ; Sonneveld, P. ; Feller, N. ; Ossenkoppele, G. J. ; Währer, D. C R ; Eekman, C. A. ; Schoester, M. ; Lankelma, J. ; Pinedo, H. M. ; Löwenberg, B. ; Schuurhuis, G. J. / Quality control of multidrug resistance assays in adult acute leukemia : Correlation between assays for P-glycoprotein expression and activity. In: Blood. 1996 ; Vol. 87, No. 11. pp. 4809-4816.
@article{2bc1a9665f2641dfa10e178a55e562d5,
title = "Quality control of multidrug resistance assays in adult acute leukemia: Correlation between assays for P-glycoprotein expression and activity",
abstract = "We have compared multiple assays for the P-glycoprotein (Pgp/MDR1) phenotype in fresh and thawed adult acute leukemia to validate and quantitate measures for the expression and function of Pgp. The results are related to the Pgp-expressing KB8 and KB8-5 cell lines. The most sensitive assay was the measurement of modulation of the rhodamine 123 (R123) fluorescence by 2 μmol/L PSC833, followed by the modulation of the probe calcein-AM. We also found a good intralaboratory and interlaboratory correlation between the values of the R123/PSC833 assay for fresh as well as thawed samples. In addition, the effects of PSC833 on 3H-daunorubicin (DNR) accumulation, DNR fluorescence, and 3H-vincristine accumulation were very similar. The correlation between the DNR/PSC833 and R123/PSC833 test was r = .86 (N = 51). The modulation of drug accumulation by 8 μmol/L verapamil was the same as the PSC833 effect for DNR (117{\%}, N = 21), but was higher for vincristine in every single case (161{\%} v 121{\%}, N = 22; P <.001), indicating additional verapamil effects, not related to Pgp. The correlation of the staining of viable cells for Pgp with the monoclonal antibody MRK16 was r = .77 (N = 52) for the R123/PSC833 functional test and r = .84 (N = 50) for the DNR/PSC833 test. From these results it could be calculated that a maximal increase of the mean DNR accumulation of about 50{\%} can be achieved by blocking Pgp pump activity with PSC833 in leukemic blast samples with the highest mean Pgp expression. Subpopulations of blast cells with higher Pgp activity are likely to be present. Their relevance has to be studied further. The methods outlined here allow the reliable, quantitative monitoring of the Pgp/MDR1 phenotype in leukemias in multicentered, clinical Pgp modulation studies.",
author = "Broxterman, {H. J.} and P. Sonneveld and N. Feller and Ossenkoppele, {G. J.} and W{\"a}hrer, {D. C R} and Eekman, {C. A.} and M. Schoester and J. Lankelma and Pinedo, {H. M.} and B. L{\"o}wenberg and Schuurhuis, {G. J.}",
year = "1996",
month = "6",
day = "1",
language = "English (US)",
volume = "87",
pages = "4809--4816",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "11",

}

TY - JOUR

T1 - Quality control of multidrug resistance assays in adult acute leukemia

T2 - Correlation between assays for P-glycoprotein expression and activity

AU - Broxterman, H. J.

AU - Sonneveld, P.

AU - Feller, N.

AU - Ossenkoppele, G. J.

AU - Währer, D. C R

AU - Eekman, C. A.

AU - Schoester, M.

AU - Lankelma, J.

AU - Pinedo, H. M.

AU - Löwenberg, B.

AU - Schuurhuis, G. J.

PY - 1996/6/1

Y1 - 1996/6/1

N2 - We have compared multiple assays for the P-glycoprotein (Pgp/MDR1) phenotype in fresh and thawed adult acute leukemia to validate and quantitate measures for the expression and function of Pgp. The results are related to the Pgp-expressing KB8 and KB8-5 cell lines. The most sensitive assay was the measurement of modulation of the rhodamine 123 (R123) fluorescence by 2 μmol/L PSC833, followed by the modulation of the probe calcein-AM. We also found a good intralaboratory and interlaboratory correlation between the values of the R123/PSC833 assay for fresh as well as thawed samples. In addition, the effects of PSC833 on 3H-daunorubicin (DNR) accumulation, DNR fluorescence, and 3H-vincristine accumulation were very similar. The correlation between the DNR/PSC833 and R123/PSC833 test was r = .86 (N = 51). The modulation of drug accumulation by 8 μmol/L verapamil was the same as the PSC833 effect for DNR (117%, N = 21), but was higher for vincristine in every single case (161% v 121%, N = 22; P <.001), indicating additional verapamil effects, not related to Pgp. The correlation of the staining of viable cells for Pgp with the monoclonal antibody MRK16 was r = .77 (N = 52) for the R123/PSC833 functional test and r = .84 (N = 50) for the DNR/PSC833 test. From these results it could be calculated that a maximal increase of the mean DNR accumulation of about 50% can be achieved by blocking Pgp pump activity with PSC833 in leukemic blast samples with the highest mean Pgp expression. Subpopulations of blast cells with higher Pgp activity are likely to be present. Their relevance has to be studied further. The methods outlined here allow the reliable, quantitative monitoring of the Pgp/MDR1 phenotype in leukemias in multicentered, clinical Pgp modulation studies.

AB - We have compared multiple assays for the P-glycoprotein (Pgp/MDR1) phenotype in fresh and thawed adult acute leukemia to validate and quantitate measures for the expression and function of Pgp. The results are related to the Pgp-expressing KB8 and KB8-5 cell lines. The most sensitive assay was the measurement of modulation of the rhodamine 123 (R123) fluorescence by 2 μmol/L PSC833, followed by the modulation of the probe calcein-AM. We also found a good intralaboratory and interlaboratory correlation between the values of the R123/PSC833 assay for fresh as well as thawed samples. In addition, the effects of PSC833 on 3H-daunorubicin (DNR) accumulation, DNR fluorescence, and 3H-vincristine accumulation were very similar. The correlation between the DNR/PSC833 and R123/PSC833 test was r = .86 (N = 51). The modulation of drug accumulation by 8 μmol/L verapamil was the same as the PSC833 effect for DNR (117%, N = 21), but was higher for vincristine in every single case (161% v 121%, N = 22; P <.001), indicating additional verapamil effects, not related to Pgp. The correlation of the staining of viable cells for Pgp with the monoclonal antibody MRK16 was r = .77 (N = 52) for the R123/PSC833 functional test and r = .84 (N = 50) for the DNR/PSC833 test. From these results it could be calculated that a maximal increase of the mean DNR accumulation of about 50% can be achieved by blocking Pgp pump activity with PSC833 in leukemic blast samples with the highest mean Pgp expression. Subpopulations of blast cells with higher Pgp activity are likely to be present. Their relevance has to be studied further. The methods outlined here allow the reliable, quantitative monitoring of the Pgp/MDR1 phenotype in leukemias in multicentered, clinical Pgp modulation studies.

UR - http://www.scopus.com/inward/record.url?scp=9344264652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9344264652&partnerID=8YFLogxK

M3 - Article

C2 - 8639853

AN - SCOPUS:9344264652

VL - 87

SP - 4809

EP - 4816

JO - Blood

JF - Blood

SN - 0006-4971

IS - 11

ER -